Copyright
©The Author(s) 2017.
World J Gastroenterol. Jul 21, 2017; 23(27): 4856-4866
Published online Jul 21, 2017. doi: 10.3748/wjg.v23.i27.4856
Published online Jul 21, 2017. doi: 10.3748/wjg.v23.i27.4856
Degree of risk | NIH criteria | AFIP criteria |
Unknown | - | < 2 cm and ≤ 5 mitotic index |
Very low | < 2 cm and < 5 mitotic index | ≤ 5 cm and ≤ 5 mitotic index |
Low | 2-5 cm and < 5 mitotic index | Gastric: > 5 cm and ≤ 5 mitotic index |
Others: 2-5 cm and ≤ 5 mitotic index | ||
Intermediate or moderate | 5-10 cm and < 5 mitotic index | Gastric: > 10 cm and ≤ 5 mitotic index or > 2-5 cm and > 5 mitotic index |
> 5 cm and 6-10 mitotic index | Others: 5-10 cm and ≤ 5 mitotic index | |
High | > 5 cm and > 5 mitotic index | Gastric: > 5 cm and > 5 mitotic index |
> 10 cm and any mitotic index | Others: > 10 cm and > 5 mitotic index | |
Any size and > 10 mitotic index |
- Citation: Lim KT, Tan KY. Current research and treatment for gastrointestinal stromal tumors. World J Gastroenterol 2017; 23(27): 4856-4866
- URL: https://www.wjgnet.com/1007-9327/full/v23/i27/4856.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i27.4856